Cargando…
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
The lysosomal cysteine protease Cathepsin K is elevated in humans and animal models of heart failure. Our recent studies show that whole-body deletion of Cathepsin K protects mice against cardiac dysfunction. Whether this is attributable to a direct effect on cardiomyocytes or is a consequence of th...
Autores principales: | Guo, Rui, Hua, Yinan, Ren, Jun, Bornfeldt, Karin E., Nair, Sreejayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992138/ https://www.ncbi.nlm.nih.gov/pubmed/29880809 http://dx.doi.org/10.1038/s41419-018-0727-2 |
Ejemplares similares
-
Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2019) -
Cathepsin K knockout protects against cardiac dysfunction in diabetic mice
por: Guo, Rui, et al.
Publicado: (2017) -
Cathepsin K knockout alleviates aging-induced cardiac dysfunction
por: Hua, Yinan, et al.
Publicado: (2015) -
Cathepsin K Knockout Mitigates High-Fat Diet–Induced Cardiac Hypertrophy and Contractile Dysfunction
por: Hua, Yinan, et al.
Publicado: (2013) -
Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023)